nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—Topoisomerase Inhibitors—Etoposide—muscle cancer	0.333	0.611	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—muscle cancer	0.212	0.389	CiPCiCtD
Topotecan—peripheral nervous system neoplasm—muscle cancer	0.152	0.507	CtDrD
Topotecan—lung cancer—muscle cancer	0.148	0.494	CtDrD
Topotecan—ABCG2—Dactinomycin—muscle cancer	0.0287	0.231	CbGbCtD
Topotecan—ABCG2—Vincristine—muscle cancer	0.0177	0.142	CbGbCtD
Topotecan—ABCG2—Etoposide—muscle cancer	0.0162	0.13	CbGbCtD
Topotecan—ABCG2—Doxorubicin—muscle cancer	0.011	0.0888	CbGbCtD
Topotecan—ABCG2—Methotrexate—muscle cancer	0.0107	0.086	CbGbCtD
Topotecan—ABCB1—Dactinomycin—muscle cancer	0.0103	0.0832	CbGbCtD
Topotecan—ABCB1—Vincristine—muscle cancer	0.00637	0.0512	CbGbCtD
Topotecan—ABCB1—Etoposide—muscle cancer	0.00584	0.0469	CbGbCtD
Topotecan—ABCB1—Doxorubicin—muscle cancer	0.00398	0.032	CbGbCtD
Topotecan—ABCB1—Methotrexate—muscle cancer	0.00386	0.031	CbGbCtD
Topotecan—CYP3A4—Vincristine—muscle cancer	0.00382	0.0307	CbGbCtD
Topotecan—CYP3A4—Etoposide—muscle cancer	0.0035	0.0281	CbGbCtD
Topotecan—CYP3A4—Doxorubicin—muscle cancer	0.00238	0.0192	CbGbCtD
Topotecan—Extravasation—Doxorubicin—muscle cancer	0.000113	0.00386	CcSEcCtD
Topotecan—Neutropenia—Etoposide—muscle cancer	0.000111	0.00381	CcSEcCtD
Topotecan—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.000108	0.0037	CcSEcCtD
Topotecan—Pneumonia—Etoposide—muscle cancer	0.000107	0.00365	CcSEcCtD
Topotecan—Angiopathy—Vincristine—muscle cancer	0.000107	0.00365	CcSEcCtD
Topotecan—Ill-defined disorder—Dactinomycin—muscle cancer	0.000106	0.00364	CcSEcCtD
Topotecan—Infestation—Etoposide—muscle cancer	0.000106	0.00363	CcSEcCtD
Topotecan—Infestation NOS—Etoposide—muscle cancer	0.000106	0.00363	CcSEcCtD
Topotecan—Mediastinal disorder—Vincristine—muscle cancer	0.000106	0.00363	CcSEcCtD
Topotecan—Anaemia—Dactinomycin—muscle cancer	0.000106	0.00363	CcSEcCtD
Topotecan—Blood bilirubin increased—Doxorubicin—muscle cancer	0.000104	0.00356	CcSEcCtD
Topotecan—Neuropathy peripheral—Etoposide—muscle cancer	0.000104	0.00356	CcSEcCtD
Topotecan—Alopecia—Vincristine—muscle cancer	0.000104	0.00356	CcSEcCtD
Topotecan—Stomatitis—Etoposide—muscle cancer	0.000103	0.00354	CcSEcCtD
Topotecan—Malaise—Dactinomycin—muscle cancer	0.000103	0.00354	CcSEcCtD
Topotecan—Neoplasm—Methotrexate—muscle cancer	0.000103	0.00352	CcSEcCtD
Topotecan—Bone pain—Doxorubicin—muscle cancer	0.000103	0.00352	CcSEcCtD
Topotecan—Leukopenia—Dactinomycin—muscle cancer	0.000103	0.00351	CcSEcCtD
Topotecan—Hepatobiliary disease—Etoposide—muscle cancer	0.0001	0.00344	CcSEcCtD
Topotecan—Back pain—Vincristine—muscle cancer	9.9e-05	0.00339	CcSEcCtD
Topotecan—Sepsis—Methotrexate—muscle cancer	9.86e-05	0.00338	CcSEcCtD
Topotecan—Pulmonary embolism—Doxorubicin—muscle cancer	9.84e-05	0.00337	CcSEcCtD
Topotecan—Myalgia—Dactinomycin—muscle cancer	9.75e-05	0.00334	CcSEcCtD
Topotecan—Discomfort—Dactinomycin—muscle cancer	9.63e-05	0.0033	CcSEcCtD
Topotecan—Hypoaesthesia—Etoposide—muscle cancer	9.47e-05	0.00324	CcSEcCtD
Topotecan—Anaemia—Vincristine—muscle cancer	9.46e-05	0.00324	CcSEcCtD
Topotecan—Colitis—Doxorubicin—muscle cancer	9.44e-05	0.00323	CcSEcCtD
Topotecan—Infection—Dactinomycin—muscle cancer	9.29e-05	0.00318	CcSEcCtD
Topotecan—Neuropathy—Doxorubicin—muscle cancer	9.23e-05	0.00316	CcSEcCtD
Topotecan—Leukopenia—Vincristine—muscle cancer	9.16e-05	0.00314	CcSEcCtD
Topotecan—Thrombocytopenia—Dactinomycin—muscle cancer	9.15e-05	0.00313	CcSEcCtD
Topotecan—Rash maculo-papular—Doxorubicin—muscle cancer	8.94e-05	0.00306	CcSEcCtD
Topotecan—Anorexia—Dactinomycin—muscle cancer	8.91e-05	0.00305	CcSEcCtD
Topotecan—Neoplasm—Doxorubicin—muscle cancer	8.89e-05	0.00305	CcSEcCtD
Topotecan—Myalgia—Vincristine—muscle cancer	8.71e-05	0.00298	CcSEcCtD
Topotecan—Angiopathy—Etoposide—muscle cancer	8.64e-05	0.00296	CcSEcCtD
Topotecan—Immune system disorder—Etoposide—muscle cancer	8.6e-05	0.00295	CcSEcCtD
Topotecan—Mediastinal disorder—Etoposide—muscle cancer	8.58e-05	0.00294	CcSEcCtD
Topotecan—Chills—Etoposide—muscle cancer	8.54e-05	0.00293	CcSEcCtD
Topotecan—Sepsis—Doxorubicin—muscle cancer	8.53e-05	0.00292	CcSEcCtD
Topotecan—Anaphylactoid reaction—Methotrexate—muscle cancer	8.52e-05	0.00292	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Dactinomycin—muscle cancer	8.52e-05	0.00292	CcSEcCtD
Topotecan—Alopecia—Etoposide—muscle cancer	8.41e-05	0.00288	CcSEcCtD
Topotecan—Lethargy—Methotrexate—muscle cancer	8.41e-05	0.00288	CcSEcCtD
Topotecan—Anaphylactic shock—Vincristine—muscle cancer	8.35e-05	0.00286	CcSEcCtD
Topotecan—Infection—Vincristine—muscle cancer	8.3e-05	0.00284	CcSEcCtD
Topotecan—Nervous system disorder—Vincristine—muscle cancer	8.19e-05	0.0028	CcSEcCtD
Topotecan—Thrombocytopenia—Vincristine—muscle cancer	8.18e-05	0.0028	CcSEcCtD
Topotecan—Decreased appetite—Dactinomycin—muscle cancer	8.13e-05	0.00278	CcSEcCtD
Topotecan—Hyperhidrosis—Vincristine—muscle cancer	8.07e-05	0.00277	CcSEcCtD
Topotecan—Fatigue—Dactinomycin—muscle cancer	8.06e-05	0.00276	CcSEcCtD
Topotecan—Back pain—Etoposide—muscle cancer	8.02e-05	0.00275	CcSEcCtD
Topotecan—Pain—Dactinomycin—muscle cancer	7.99e-05	0.00274	CcSEcCtD
Topotecan—Muscle spasms—Etoposide—muscle cancer	7.97e-05	0.00273	CcSEcCtD
Topotecan—Anorexia—Vincristine—muscle cancer	7.96e-05	0.00273	CcSEcCtD
Topotecan—TOP1MT—head—muscle cancer	7.84e-05	0.137	CbGeAlD
Topotecan—Feeling abnormal—Dactinomycin—muscle cancer	7.7e-05	0.00264	CcSEcCtD
Topotecan—Ill-defined disorder—Etoposide—muscle cancer	7.69e-05	0.00263	CcSEcCtD
Topotecan—Anaemia—Etoposide—muscle cancer	7.66e-05	0.00262	CcSEcCtD
Topotecan—Gastrointestinal pain—Dactinomycin—muscle cancer	7.64e-05	0.00262	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Vincristine—muscle cancer	7.61e-05	0.00261	CcSEcCtD
Topotecan—TOP1MT—testis—muscle cancer	7.58e-05	0.133	CbGeAlD
Topotecan—Paraesthesia—Vincristine—muscle cancer	7.5e-05	0.00257	CcSEcCtD
Topotecan—Malaise—Etoposide—muscle cancer	7.48e-05	0.00256	CcSEcCtD
Topotecan—Dermatitis bullous—Doxorubicin—muscle cancer	7.47e-05	0.00256	CcSEcCtD
Topotecan—Leukopenia—Etoposide—muscle cancer	7.42e-05	0.00254	CcSEcCtD
Topotecan—Body temperature increased—Dactinomycin—muscle cancer	7.39e-05	0.00253	CcSEcCtD
Topotecan—Abdominal pain—Dactinomycin—muscle cancer	7.39e-05	0.00253	CcSEcCtD
Topotecan—Anaphylactoid reaction—Doxorubicin—muscle cancer	7.38e-05	0.00253	CcSEcCtD
Topotecan—Lethargy—Doxorubicin—muscle cancer	7.29e-05	0.0025	CcSEcCtD
Topotecan—Decreased appetite—Vincristine—muscle cancer	7.26e-05	0.00249	CcSEcCtD
Topotecan—Cough—Etoposide—muscle cancer	7.23e-05	0.00248	CcSEcCtD
Topotecan—Gastrointestinal disorder—Vincristine—muscle cancer	7.21e-05	0.00247	CcSEcCtD
Topotecan—Fatigue—Vincristine—muscle cancer	7.2e-05	0.00247	CcSEcCtD
Topotecan—Pain—Vincristine—muscle cancer	7.14e-05	0.00245	CcSEcCtD
Topotecan—Constipation—Vincristine—muscle cancer	7.14e-05	0.00245	CcSEcCtD
Topotecan—Chest pain—Etoposide—muscle cancer	7.06e-05	0.00242	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	7.01e-05	0.0024	CcSEcCtD
Topotecan—Discomfort—Etoposide—muscle cancer	6.97e-05	0.00239	CcSEcCtD
Topotecan—Hypersensitivity—Dactinomycin—muscle cancer	6.89e-05	0.00236	CcSEcCtD
Topotecan—Gastrointestinal pain—Vincristine—muscle cancer	6.83e-05	0.00234	CcSEcCtD
Topotecan—Cardiac arrest—Doxorubicin—muscle cancer	6.79e-05	0.00232	CcSEcCtD
Topotecan—Pancytopenia—Methotrexate—muscle cancer	6.77e-05	0.00232	CcSEcCtD
Topotecan—Anaphylactic shock—Etoposide—muscle cancer	6.77e-05	0.00232	CcSEcCtD
Topotecan—Infection—Etoposide—muscle cancer	6.72e-05	0.0023	CcSEcCtD
Topotecan—Asthenia—Dactinomycin—muscle cancer	6.71e-05	0.0023	CcSEcCtD
Topotecan—Neutropenia—Methotrexate—muscle cancer	6.66e-05	0.00228	CcSEcCtD
Topotecan—Thrombocytopenia—Etoposide—muscle cancer	6.62e-05	0.00227	CcSEcCtD
Topotecan—Body temperature increased—Vincristine—muscle cancer	6.6e-05	0.00226	CcSEcCtD
Topotecan—Abdominal pain—Vincristine—muscle cancer	6.6e-05	0.00226	CcSEcCtD
Topotecan—Skin disorder—Etoposide—muscle cancer	6.57e-05	0.00225	CcSEcCtD
Topotecan—Hyperhidrosis—Etoposide—muscle cancer	6.54e-05	0.00224	CcSEcCtD
Topotecan—Anorexia—Etoposide—muscle cancer	6.45e-05	0.00221	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	6.43e-05	0.0022	CcSEcCtD
Topotecan—TOP1—smooth muscle tissue—muscle cancer	6.42e-05	0.113	CbGeAlD
Topotecan—Diarrhoea—Dactinomycin—muscle cancer	6.4e-05	0.00219	CcSEcCtD
Topotecan—Pneumonia—Methotrexate—muscle cancer	6.39e-05	0.00219	CcSEcCtD
Topotecan—Infestation NOS—Methotrexate—muscle cancer	6.35e-05	0.00218	CcSEcCtD
Topotecan—Infestation—Methotrexate—muscle cancer	6.35e-05	0.00218	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Doxorubicin—muscle cancer	6.3e-05	0.00216	CcSEcCtD
Topotecan—Stomatitis—Methotrexate—muscle cancer	6.19e-05	0.00212	CcSEcCtD
Topotecan—Hypersensitivity—Vincristine—muscle cancer	6.15e-05	0.00211	CcSEcCtD
Topotecan—Sweating—Methotrexate—muscle cancer	6.09e-05	0.00209	CcSEcCtD
Topotecan—Paraesthesia—Etoposide—muscle cancer	6.07e-05	0.00208	CcSEcCtD
Topotecan—Dyspnoea—Etoposide—muscle cancer	6.03e-05	0.00207	CcSEcCtD
Topotecan—Hepatobiliary disease—Methotrexate—muscle cancer	6.01e-05	0.00206	CcSEcCtD
Topotecan—Epistaxis—Methotrexate—muscle cancer	5.99e-05	0.00205	CcSEcCtD
Topotecan—Asthenia—Vincristine—muscle cancer	5.99e-05	0.00205	CcSEcCtD
Topotecan—Vomiting—Dactinomycin—muscle cancer	5.94e-05	0.00204	CcSEcCtD
Topotecan—Rash—Dactinomycin—muscle cancer	5.89e-05	0.00202	CcSEcCtD
Topotecan—Decreased appetite—Etoposide—muscle cancer	5.88e-05	0.00201	CcSEcCtD
Topotecan—Pancytopenia—Doxorubicin—muscle cancer	5.86e-05	0.00201	CcSEcCtD
Topotecan—Gastrointestinal disorder—Etoposide—muscle cancer	5.84e-05	0.002	CcSEcCtD
Topotecan—Fatigue—Etoposide—muscle cancer	5.83e-05	0.002	CcSEcCtD
Topotecan—Constipation—Etoposide—muscle cancer	5.79e-05	0.00198	CcSEcCtD
Topotecan—Pain—Etoposide—muscle cancer	5.79e-05	0.00198	CcSEcCtD
Topotecan—Neutropenia—Doxorubicin—muscle cancer	5.77e-05	0.00198	CcSEcCtD
Topotecan—Haemoglobin—Methotrexate—muscle cancer	5.73e-05	0.00196	CcSEcCtD
Topotecan—Diarrhoea—Vincristine—muscle cancer	5.71e-05	0.00196	CcSEcCtD
Topotecan—Haemorrhage—Methotrexate—muscle cancer	5.7e-05	0.00195	CcSEcCtD
Topotecan—Pharyngitis—Methotrexate—muscle cancer	5.66e-05	0.00194	CcSEcCtD
Topotecan—Weight increased—Doxorubicin—muscle cancer	5.62e-05	0.00192	CcSEcCtD
Topotecan—Feeling abnormal—Etoposide—muscle cancer	5.57e-05	0.00191	CcSEcCtD
Topotecan—Nausea—Dactinomycin—muscle cancer	5.55e-05	0.0019	CcSEcCtD
Topotecan—TOP1—cardiac atrium—muscle cancer	5.54e-05	0.097	CbGeAlD
Topotecan—Pneumonia—Doxorubicin—muscle cancer	5.53e-05	0.0019	CcSEcCtD
Topotecan—Gastrointestinal pain—Etoposide—muscle cancer	5.53e-05	0.00189	CcSEcCtD
Topotecan—Dizziness—Vincristine—muscle cancer	5.52e-05	0.00189	CcSEcCtD
Topotecan—Infestation—Doxorubicin—muscle cancer	5.5e-05	0.00188	CcSEcCtD
Topotecan—Infestation NOS—Doxorubicin—muscle cancer	5.5e-05	0.00188	CcSEcCtD
Topotecan—Neuropathy peripheral—Doxorubicin—muscle cancer	5.39e-05	0.00185	CcSEcCtD
Topotecan—Urticaria—Etoposide—muscle cancer	5.37e-05	0.00184	CcSEcCtD
Topotecan—Stomatitis—Doxorubicin—muscle cancer	5.36e-05	0.00184	CcSEcCtD
Topotecan—Abdominal pain—Etoposide—muscle cancer	5.35e-05	0.00183	CcSEcCtD
Topotecan—Body temperature increased—Etoposide—muscle cancer	5.35e-05	0.00183	CcSEcCtD
Topotecan—Vomiting—Vincristine—muscle cancer	5.31e-05	0.00182	CcSEcCtD
Topotecan—Sweating—Doxorubicin—muscle cancer	5.27e-05	0.00181	CcSEcCtD
Topotecan—Rash—Vincristine—muscle cancer	5.27e-05	0.0018	CcSEcCtD
Topotecan—Dermatitis—Vincristine—muscle cancer	5.26e-05	0.0018	CcSEcCtD
Topotecan—Headache—Vincristine—muscle cancer	5.23e-05	0.00179	CcSEcCtD
Topotecan—Hepatobiliary disease—Doxorubicin—muscle cancer	5.2e-05	0.00178	CcSEcCtD
Topotecan—Epistaxis—Doxorubicin—muscle cancer	5.19e-05	0.00178	CcSEcCtD
Topotecan—Angiopathy—Methotrexate—muscle cancer	5.17e-05	0.00177	CcSEcCtD
Topotecan—Immune system disorder—Methotrexate—muscle cancer	5.15e-05	0.00176	CcSEcCtD
Topotecan—Mediastinal disorder—Methotrexate—muscle cancer	5.14e-05	0.00176	CcSEcCtD
Topotecan—Chills—Methotrexate—muscle cancer	5.12e-05	0.00175	CcSEcCtD
Topotecan—Alopecia—Methotrexate—muscle cancer	5.04e-05	0.00173	CcSEcCtD
Topotecan—Hypersensitivity—Etoposide—muscle cancer	4.98e-05	0.00171	CcSEcCtD
Topotecan—Malnutrition—Methotrexate—muscle cancer	4.97e-05	0.0017	CcSEcCtD
Topotecan—Haemoglobin—Doxorubicin—muscle cancer	4.96e-05	0.0017	CcSEcCtD
Topotecan—Nausea—Vincristine—muscle cancer	4.96e-05	0.0017	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—muscle cancer	4.95e-05	0.0017	CcSEcCtD
Topotecan—Haemorrhage—Doxorubicin—muscle cancer	4.94e-05	0.00169	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—muscle cancer	4.91e-05	0.00168	CcSEcCtD
Topotecan—Pharyngitis—Doxorubicin—muscle cancer	4.9e-05	0.00168	CcSEcCtD
Topotecan—Asthenia—Etoposide—muscle cancer	4.85e-05	0.00166	CcSEcCtD
Topotecan—TOP1—tendon—muscle cancer	4.83e-05	0.0845	CbGeAlD
Topotecan—Back pain—Methotrexate—muscle cancer	4.8e-05	0.00164	CcSEcCtD
Topotecan—Pruritus—Etoposide—muscle cancer	4.79e-05	0.00164	CcSEcCtD
Topotecan—TOP1—bone marrow—muscle cancer	4.68e-05	0.0819	CbGeAlD
Topotecan—Diarrhoea—Etoposide—muscle cancer	4.63e-05	0.00159	CcSEcCtD
Topotecan—Ill-defined disorder—Methotrexate—muscle cancer	4.61e-05	0.00158	CcSEcCtD
Topotecan—Anaemia—Methotrexate—muscle cancer	4.59e-05	0.00157	CcSEcCtD
Topotecan—Angiopathy—Doxorubicin—muscle cancer	4.48e-05	0.00153	CcSEcCtD
Topotecan—TOP1—vagina—muscle cancer	4.48e-05	0.0784	CbGeAlD
Topotecan—Malaise—Methotrexate—muscle cancer	4.48e-05	0.00153	CcSEcCtD
Topotecan—Dizziness—Etoposide—muscle cancer	4.47e-05	0.00153	CcSEcCtD
Topotecan—Immune system disorder—Doxorubicin—muscle cancer	4.46e-05	0.00153	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—muscle cancer	4.45e-05	0.00152	CcSEcCtD
Topotecan—Leukopenia—Methotrexate—muscle cancer	4.44e-05	0.00152	CcSEcCtD
Topotecan—Chills—Doxorubicin—muscle cancer	4.43e-05	0.00152	CcSEcCtD
Topotecan—Alopecia—Doxorubicin—muscle cancer	4.36e-05	0.00149	CcSEcCtD
Topotecan—Cough—Methotrexate—muscle cancer	4.33e-05	0.00148	CcSEcCtD
Topotecan—Vomiting—Etoposide—muscle cancer	4.3e-05	0.00147	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—muscle cancer	4.3e-05	0.00147	CcSEcCtD
Topotecan—Rash—Etoposide—muscle cancer	4.27e-05	0.00146	CcSEcCtD
Topotecan—Dermatitis—Etoposide—muscle cancer	4.26e-05	0.00146	CcSEcCtD
Topotecan—Headache—Etoposide—muscle cancer	4.24e-05	0.00145	CcSEcCtD
Topotecan—Chest pain—Methotrexate—muscle cancer	4.23e-05	0.00145	CcSEcCtD
Topotecan—Myalgia—Methotrexate—muscle cancer	4.23e-05	0.00145	CcSEcCtD
Topotecan—Arthralgia—Methotrexate—muscle cancer	4.23e-05	0.00145	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	4.2e-05	0.00144	CcSEcCtD
Topotecan—Discomfort—Methotrexate—muscle cancer	4.18e-05	0.00143	CcSEcCtD
Topotecan—Back pain—Doxorubicin—muscle cancer	4.16e-05	0.00142	CcSEcCtD
Topotecan—Muscle spasms—Doxorubicin—muscle cancer	4.13e-05	0.00142	CcSEcCtD
Topotecan—Anaphylactic shock—Methotrexate—muscle cancer	4.05e-05	0.00139	CcSEcCtD
Topotecan—Infection—Methotrexate—muscle cancer	4.03e-05	0.00138	CcSEcCtD
Topotecan—Nausea—Etoposide—muscle cancer	4.02e-05	0.00138	CcSEcCtD
Topotecan—TOP1—testis—muscle cancer	4e-05	0.07	CbGeAlD
Topotecan—Ill-defined disorder—Doxorubicin—muscle cancer	3.99e-05	0.00137	CcSEcCtD
Topotecan—Nervous system disorder—Methotrexate—muscle cancer	3.97e-05	0.00136	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—muscle cancer	3.97e-05	0.00136	CcSEcCtD
Topotecan—Thrombocytopenia—Methotrexate—muscle cancer	3.97e-05	0.00136	CcSEcCtD
Topotecan—Skin disorder—Methotrexate—muscle cancer	3.94e-05	0.00135	CcSEcCtD
Topotecan—Hyperhidrosis—Methotrexate—muscle cancer	3.92e-05	0.00134	CcSEcCtD
Topotecan—Malaise—Doxorubicin—muscle cancer	3.88e-05	0.00133	CcSEcCtD
Topotecan—Anorexia—Methotrexate—muscle cancer	3.86e-05	0.00132	CcSEcCtD
Topotecan—Leukopenia—Doxorubicin—muscle cancer	3.85e-05	0.00132	CcSEcCtD
Topotecan—Cough—Doxorubicin—muscle cancer	3.75e-05	0.00128	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Methotrexate—muscle cancer	3.69e-05	0.00126	CcSEcCtD
Topotecan—Chest pain—Doxorubicin—muscle cancer	3.66e-05	0.00125	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—muscle cancer	3.66e-05	0.00125	CcSEcCtD
Topotecan—Arthralgia—Doxorubicin—muscle cancer	3.66e-05	0.00125	CcSEcCtD
Topotecan—Paraesthesia—Methotrexate—muscle cancer	3.64e-05	0.00125	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	3.64e-05	0.00124	CcSEcCtD
Topotecan—Discomfort—Doxorubicin—muscle cancer	3.62e-05	0.00124	CcSEcCtD
Topotecan—Dyspnoea—Methotrexate—muscle cancer	3.61e-05	0.00124	CcSEcCtD
Topotecan—Dyspepsia—Methotrexate—muscle cancer	3.57e-05	0.00122	CcSEcCtD
Topotecan—Decreased appetite—Methotrexate—muscle cancer	3.52e-05	0.00121	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—muscle cancer	3.51e-05	0.0012	CcSEcCtD
Topotecan—Gastrointestinal disorder—Methotrexate—muscle cancer	3.5e-05	0.0012	CcSEcCtD
Topotecan—Fatigue—Methotrexate—muscle cancer	3.49e-05	0.0012	CcSEcCtD
Topotecan—Infection—Doxorubicin—muscle cancer	3.49e-05	0.00119	CcSEcCtD
Topotecan—Pain—Methotrexate—muscle cancer	3.47e-05	0.00119	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—muscle cancer	3.44e-05	0.00118	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—muscle cancer	3.44e-05	0.00118	CcSEcCtD
Topotecan—Skin disorder—Doxorubicin—muscle cancer	3.41e-05	0.00117	CcSEcCtD
Topotecan—Hyperhidrosis—Doxorubicin—muscle cancer	3.39e-05	0.00116	CcSEcCtD
Topotecan—Anorexia—Doxorubicin—muscle cancer	3.34e-05	0.00115	CcSEcCtD
Topotecan—Feeling abnormal—Methotrexate—muscle cancer	3.34e-05	0.00114	CcSEcCtD
Topotecan—Gastrointestinal pain—Methotrexate—muscle cancer	3.31e-05	0.00113	CcSEcCtD
Topotecan—Urticaria—Methotrexate—muscle cancer	3.22e-05	0.0011	CcSEcCtD
Topotecan—Abdominal pain—Methotrexate—muscle cancer	3.2e-05	0.0011	CcSEcCtD
Topotecan—Body temperature increased—Methotrexate—muscle cancer	3.2e-05	0.0011	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Doxorubicin—muscle cancer	3.2e-05	0.00109	CcSEcCtD
Topotecan—Paraesthesia—Doxorubicin—muscle cancer	3.15e-05	0.00108	CcSEcCtD
Topotecan—Dyspnoea—Doxorubicin—muscle cancer	3.13e-05	0.00107	CcSEcCtD
Topotecan—Dyspepsia—Doxorubicin—muscle cancer	3.09e-05	0.00106	CcSEcCtD
Topotecan—Decreased appetite—Doxorubicin—muscle cancer	3.05e-05	0.00104	CcSEcCtD
Topotecan—Gastrointestinal disorder—Doxorubicin—muscle cancer	3.03e-05	0.00104	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—muscle cancer	3.03e-05	0.00104	CcSEcCtD
Topotecan—Constipation—Doxorubicin—muscle cancer	3e-05	0.00103	CcSEcCtD
Topotecan—Pain—Doxorubicin—muscle cancer	3e-05	0.00103	CcSEcCtD
Topotecan—Hypersensitivity—Methotrexate—muscle cancer	2.99e-05	0.00102	CcSEcCtD
Topotecan—Asthenia—Methotrexate—muscle cancer	2.91e-05	0.000996	CcSEcCtD
Topotecan—Feeling abnormal—Doxorubicin—muscle cancer	2.89e-05	0.00099	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—muscle cancer	2.87e-05	0.000983	CcSEcCtD
Topotecan—Pruritus—Methotrexate—muscle cancer	2.87e-05	0.000982	CcSEcCtD
Topotecan—Urticaria—Doxorubicin—muscle cancer	2.79e-05	0.000955	CcSEcCtD
Topotecan—Body temperature increased—Doxorubicin—muscle cancer	2.77e-05	0.00095	CcSEcCtD
Topotecan—Abdominal pain—Doxorubicin—muscle cancer	2.77e-05	0.00095	CcSEcCtD
Topotecan—Diarrhoea—Methotrexate—muscle cancer	2.77e-05	0.00095	CcSEcCtD
Topotecan—Dizziness—Methotrexate—muscle cancer	2.68e-05	0.000918	CcSEcCtD
Topotecan—Hypersensitivity—Doxorubicin—muscle cancer	2.59e-05	0.000885	CcSEcCtD
Topotecan—Vomiting—Methotrexate—muscle cancer	2.58e-05	0.000882	CcSEcCtD
Topotecan—Rash—Methotrexate—muscle cancer	2.55e-05	0.000875	CcSEcCtD
Topotecan—Dermatitis—Methotrexate—muscle cancer	2.55e-05	0.000874	CcSEcCtD
Topotecan—Headache—Methotrexate—muscle cancer	2.54e-05	0.000869	CcSEcCtD
Topotecan—Asthenia—Doxorubicin—muscle cancer	2.52e-05	0.000862	CcSEcCtD
Topotecan—Pruritus—Doxorubicin—muscle cancer	2.48e-05	0.00085	CcSEcCtD
Topotecan—Nausea—Methotrexate—muscle cancer	2.41e-05	0.000824	CcSEcCtD
Topotecan—Diarrhoea—Doxorubicin—muscle cancer	2.4e-05	0.000822	CcSEcCtD
Topotecan—Dizziness—Doxorubicin—muscle cancer	2.32e-05	0.000795	CcSEcCtD
Topotecan—Vomiting—Doxorubicin—muscle cancer	2.23e-05	0.000764	CcSEcCtD
Topotecan—Rash—Doxorubicin—muscle cancer	2.21e-05	0.000758	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—muscle cancer	2.21e-05	0.000757	CcSEcCtD
Topotecan—Headache—Doxorubicin—muscle cancer	2.2e-05	0.000753	CcSEcCtD
Topotecan—Nausea—Doxorubicin—muscle cancer	2.08e-05	0.000714	CcSEcCtD
Topotecan—ABCG2—bone marrow—muscle cancer	1.66e-05	0.029	CbGeAlD
Topotecan—ABCG2—vagina—muscle cancer	1.59e-05	0.0278	CbGeAlD
Topotecan—CYP3A4—renal system—muscle cancer	1.53e-05	0.0268	CbGeAlD
Topotecan—ABCB1—embryo—muscle cancer	1.43e-05	0.025	CbGeAlD
Topotecan—ABCG2—testis—muscle cancer	1.42e-05	0.0248	CbGeAlD
Topotecan—ABCB1—renal system—muscle cancer	1.08e-05	0.0189	CbGeAlD
Topotecan—ABCB1—bone marrow—muscle cancer	8.18e-06	0.0143	CbGeAlD
Topotecan—ABCB1—vagina—muscle cancer	7.83e-06	0.0137	CbGeAlD
Topotecan—ABCB1—head—muscle cancer	7.24e-06	0.0127	CbGeAlD
Topotecan—ABCB1—testis—muscle cancer	6.99e-06	0.0122	CbGeAlD
